TARPLIN, DOWNS & YOUNG, LLC

Lobbying for IDORSIA PHARMACEUTICALS US INC · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $50,000.00 income · posted Jul 16, 2025

Lobbying activity 1

Health Issues

policies related to the regulation of and access to insomnia treatments

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.